Aspirin
Phase 3Terminated 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Colon Adenomas
Conditions
Colon Adenomas
Trial Timeline
Mar 1, 1997 → Mar 1, 1999
NCT ID
NCT00224679About Aspirin
Aspirin is a phase 3 stage product being developed by Sanofi for Colon Adenomas. The current trial status is terminated. This product is registered under clinical trial identifier NCT00224679. Target conditions include Colon Adenomas.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00224679 | Phase 3 | Terminated |
Competing Products
20 competing products in Colon Adenomas